GWGernold Wozniak

Gernold Wozniak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gernold Wozniak has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Intracellular Adhesion Molecule-1 in Patients Developing Pulmonary Insufficiency after Cardiopulmonary Bypass

    by G Görlach, J Sroka, M Heidt, I Knez, A Sablotzki, M Schönburg, H Akintürk, P Roth, G Wozniak, P R Vogt

    Objectives: Cardiopulmonary bypass activates adhesion molecules, which are associated with systemic inflammation and organ dysfunction. The intracellular adhesion molecule-1 (ICAM-1) has been evaluated in patients presenting pulmonary dysfunction after cardiac surgery. Materials and Methods: Postoperative serum levels of the ICAM-1 were measured in 40 patients who underwent isolated coronary artery bypass grafting, in 28 with uneventful postoperative recovery (70 %) (Group 1), and in 12 (30 %) with postoperative respiratory insufficiency (Group 2), defined by the need for prolonged (> 24 hours) mechanical ventilation using a fractional oxygen concentration of > 40 %. Results: Patients in group 1 were ventilated for 12.21 ± 4.86 hours and those in group 2 for 92.91 ± 48.14 hours (p < 0.001). ICAM-1 decreased from 145.98 ± 73.40 ng/ml to 81.15 ± 114.82 ng/ml in group 1, while in group 2 ICAM-1 showed a significant higher level and increased to 435.01 ± 130.02 ng/ml (p < 0.001). The leukocyte count increased in both groups as well as the C-reactive protein (CRP) during the postoperative course. The CRP behaves similar in both groups (p = 0.636) in contrast to the leukocyte count which was significantly higher in group 2 (p < 0.01). While none of the patients in group 1 died the mortality in group 2 was 50 % (p < 0.001). Conclusion: Respiratory insufficiency after cardiopulmonary bypass is associated with a distinct increase in the ICAM-1. The reason for the increase of the ICAM-1 in this small subset of patients has not been clarified.


  • Factor XIII Prevents Development of Myocardial Edema in Children Undergoing Surgery for Congenital Heart Disease

    by Gernold Wozniak, Thomas Noll, Hakan Akintürk, Josef Thul, Matthias Müller

    In a prospective investigation of perioperative cardiac edema formation requiring a delayed sternal closure, we identified thrombin increase combined with a simultaneous decrease of factor XIII as a probable cause. After experimental studies additionally revealed that factor XIII could protect endothelial barrier function, we did another prospective randomized trial in which factor XIII or placebo was preoperatively substituted. The substitution finally showed distinct effects minimizing the incidence of myocardial swelling. Therefore, the clinical application of factor XIII may have a valuable therapeutic benefit in cases of leakage syndrome during extracorporeal circulation in congenital heart surgery.


  • Lokalapplikation des Fibrin-stabilisierenden Faktors beim venösen Ulkus: experimentelle Untersuchung zum Effekt auf die Gefäßpermeabilität

    by G Wozniak, T Noll, U Brunner, F W Hehrlein

    Background: The clinical observation of distinct reduction of wound secretion tendency during treatment of venous leg ulcer with topically applied factor XIII let us speculate that this enzyme may be involved in modulation of vascular permeability. Methods: For experimental study porcine aortic endothelial cells were cultured on filter membrane to confluent monolayer. Endothelial covered filters then were used in a two-compartment modell creating an artificial luminal and abluminal compartment. To investigate the influence of factor XIII on endothelial barrier function, we measured the flux of trypan blue-labeled albumin through endothelial monolayers by spectrophotometer. Results: Monolayers that were exposed to factor XIII showed a distinct (n = 10, p < 0.05) decrease of albumin flux in contrast to control. This effect was not dependent on serum substrates. Partially, the permeability reducing effect was due to a certain amount of albumin that is a stabilizing component of Fibrogammin®HS. Conclusion: Although the mechanism is unclear at the moment, we conclude that reduction of endothelial permeability can be achieved by factor XIII which may play an important role in wound healing of venous leg ulcer.


    • 1 January 1999
      • p. 73-7

    [Factor XIII: experimental and clinical results in diabetic foot ulcer].

    by G Wozniak, T Noll, U Bott, F W Hehrlein

    Several diseases show an impairment of vascular barrier function. In the past, we found out that topically applied plasmatic factor XIII distinctly reduced secretion tendency and improved granulation in venous ulcer. Increased vascular permeability is also discussed in patients with a long lasting diabetic status being a relevant cause of impaired local wound healing. Therefore, we introduced the topical application of factor XIII into the therapy of diabetic foot ulcer. After basic experimental investigations revealed that factor XIII significantly reduces endothelial permeability of cultured endothelial cells, the first clinically treated diabetic patients showed encouraging results, too.

    • 1 August 1998
      • Vol. 39  (4) , 405-11

    Superficial femoral vein in arterial reconstruction for limb salvage: outcome and fate of venous circulation.

    by G Wozniak, H Görtz, H Akintürk, F Dapper, F Hehrlein, J Alemany

    In some particular cases in vascular surgery it is mandatory to perform arterial reconstruction using autologous graft. Since 1985, we have been using the superficial femoral vein for arterial substitute in the case of limb salvage, when another autologous vein has not been available. We made a prospective investigation on 32 patients over a mean period of 24.5+/-12.1 months (1 to 48 months) to evaluate the usefulness of superficial femoral vein (SFV) for distal arterial reconstructive surgery and to objectify the fate of venous circulation of the limb after removal of this vein. There were 20 male and 12 female patients averaging 64.3+/-10.3 years, who underwent crural arterial reconstructive surgery using the composite technique (PTFE and SFV). All grafts had been placed subcutaneously in lateral to knee position. Mean length of removed superficial femoral vein was 13.2+/-9.4 cm. In 6 patients (18.7%), we found an early occlusion of bypass followed by major amputation in 5 cases (15.6%). Minor amputation had to be done in 12 patients (37.5%). Cumulative patency was 56.3% after 48 months. Following the removal of superficial femoral vein, we had no complications due to venous stasis. We found a significant increase of plethysmographically measured venous capacity (1.7+/-0.49 to 2.51+/-0.71 [p<0.01]) and venous outflow (14.9+/-5.34 to 23.9+/-10.4 [p<0.05]) after 7.7 months. We did not observe more significant changes of venous circulation during further follow-up. Despite overall good results, we only recommend the use of superficial femoral vein in hazardous situations, when other autologous material is not available.

  • An Assessment of Selective Cerebral Perfusion Via the Innominate Artery in Aortic Arch Replacement

    by G. Wozniak, F. Dapper, E. Schindler, H. Akintürk, B. Zickmann, J. Gehron, F. W. Hehrlein

    Maintaining an adequate cerebral oxygen supply is a serious problem in aortic arch surgery. Deep hypothermic circulatory arrest is the most common method used for cerebral protection, but guarantees only a time-limited safety period. Based on experimental investigations, we applied selective cerebral perfusion via the innominate artery alone with only moderate hypothermia (28°C) and without circulatory arrest in 25 consecutive patients undergoing surgical treatment of an aneurysm(n = 10) or acute type-A dissection (n = 15) involving the aortic valve and arch. In every case a test perfusion was carried out to assess whether the cerebral perfusion achieved would be adequate for the whole Operation. In no case was the perfusion inadequate. As a new perioperative monitoring System, we used computer-aided topographical electroencephalometry (CATEEM).There were 18 male and 7 female patients, their age was 47.0 ± 15.1 years (mean ± SD). Mean time periods were 155.1 ± 37.3 min for aortic cross-clamping, and 69.3 ± 35 min for selective cerebral perfusion. Postoperatively, two patients (8%) revealed a temporary left-sided hemiparesis, and 4 patients (16 %) died within 30 days. The overall mortality rate was 16% in a follow-up period of 24.2 ± 9.5 months. In this small group the CATEEM monitoring enabled an intraoperative selection of patients with sufficient bihemispheric collateral circulation and therefore suitable for simple innominate artery perfusion.